Verona Pharma (VRP)

 

Latest News

Global Offering and Application to List on NASDAQ

RNS Number: 6578C Verona Pharma PLC 19 April 2017 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO 596/2014 Verona Pharma Announces Launch of Global Offering and Application to List on the NASDAQ Global Market 19 April 2017, London - Verona Pharma plc (AIM: V...

FDA authorises start of Verona Pharma's US trial

Verona Pharma announced the US Food and Drug Administration (FDA) authorized the initiation of a pharmacokinetic ...

FDA Authorisation to Proceed RPL554 Investigation

RNS Number: 5435C Verona Pharma PLC 18 April 2017 THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO 596/2014. Verona Pharma Receives Authorization from the U.S. FDA to Proceed with Clinical Investigation of RPL554 with the Acceptance of Investigational New Drug Applic...

All resolutions passed at Verona AGM

Verona Pharma has confirmed that all resolutions proposed at the Annual General Meeting (AGM) held today were duly ...

All News

DateHeadlineSource
19-04-17Global Offering and Application to List on NASDAQRNS
18-04-17FDA authorises start of Verona Pharma's US trialStockMarketWire
18-04-17FDA Authorisation to Proceed RPL554 InvestigationRNS
12-04-17All resolutions passed at Verona AGMStockMarketWire
12-04-17Result of AGMRNS
04-04-17Files Statement for Proposed Global OfferingRNS
04-04-17Files Statement for Proposed Global OfferingRNS
04-04-171st Patient Dosed in Ph2a Trial for RPL554 in CFRNS
03-04-17Board ChangeRNS
31-03-17COPD Collaboration and New Commercial DirectorRNS
22-03-17Verona Pharma in services agreement with QuintilesIMSStockMarketWire
22-03-17Services Agreement with QuintilesIMSRNS
20-03-17Verona Pharma schedules AGMStockMarketWire
20-03-17Posting of Annual report & Notice of AGMRNS
02-03-17Director Deals - Verona Pharma PLC (VRP)StockMarketWire
02-03-17PDMR DealingRNS
27-02-17Verona Pharma narrows FY pretax lossStockMarketWire
27-02-17Final ResultsRNS
23-02-17Notice of ResultsRNS
22-02-17First COPD patient dosed with RPL554RNS
08-02-17Verona share consolidation approved by shareholdersStockMarketWire
08-02-17Result of General Meeting and Share ConsolidationRNS
18-01-17Publication of CircularRNS
11-01-17Holding(s) in CompanyRNS
04-01-17Holding(s) in CompanyRNS
29-12-16Issue of EquityRNS
23-11-16Verona Pharma plans US public offeringStockMarketWire
23-11-16Registered Initial Public Offering in the USRNS
28-10-16Exercise of optionsRNS
26-10-16Second Venture and Innovation Award from the CF TrustRNS
19-10-16Notice of Cancellation of Trading on XetraRNS
28-09-16Exercise of optionsRNS
26-09-16Appointment of CFORNS
13-09-16Half-year ReportRNS
12-09-16Appointment of Vikas Sinha as Non-Executive DirectorRNS
30-08-16Data on RPL554 to be presented at ERS CongressRNS
10-08-16Notice of ResultsRNS
09-08-16Director Deals - Verona Pharma PLC (VRP)StockMarketWire
09-08-16Director DealingRNS
05-08-16Holding(s) in CompanyRNS

RSS feeds

  • Editorial news feed for LSE:VRP Editorial
  • Regulatory news feed for LSE:VRP Regulatory